Pharmaceutical company CEOs at a conference argued with one another about drug prices. “The real reason we’re not liked, in my opinion, is because we as an industry have used price increases to cover up the gaps in innovation. That’s just a fact,” said Regeneron Pharmaceuticals CEO Leonard Schleifer.